Skip to content

Effect of the Homoeopathic Medicine Ruck-Pain" in the treatment of Spondylosis

An Open Label Prospective Randomized Controlled Study to Assess the Efficacy of the Homoeopathic Formulation ‘Ruck– Pain’ in the Treatment of Spondylosis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039286
Enrollment
50
Registered
2022-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere Health Condition 2: M47- Spondylosis Health Condition 3: M483- Traumatic spondylopathy

Interventions

Intervention1: Ruck-Pain: Homoeopathic Formulation Medicine approved by Office of the Commissioner Food Safety and Drug Administration, UP vide Letter No Drug/4706/2456 dated 30.07.2019: 20 Drops of M

Sponsors

Dr Willmar Schwabe India Pvt Ltd
Lead Sponsor
Vinayaka Missions Homoeopathic Medical College and Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Clinically and / or Radiologically Diagnosed Spondylosis Patients.

Exclusion criteria

Exclusion criteria: Congenital Spinal anomalies; fracture spine; advanced degenerative spinal conditions; severe neural cord compression; severe bony ankylosis; patients with advanced neurological symptoms; cervical rib.

Design outcomes

Primary

MeasureTime frame
Symptomatic Relief of the pain Improvement in the Mobility of the PatientTimepoint: 90 Days

Secondary

MeasureTime frame
Improvement in Quality of life of the patient, Improvement in patient mobilization, etc.,Timepoint: 90 Days

Countries

India

Contacts

Public ContactDr H Venkatesan

Vinayaka Missions Homoeopathic Medical College and Hospital Salem

venkathompath@gmail.com9865134561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026